Literature DB >> 9407218

Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.

R N Tiballi1, J E Spiegel, L T Zarins, C A Kauffman.   

Abstract

Saccharomyces cerevisiae was isolated in large numbers from operative specimens from two patients with perforated bowel and peritonitis and from the blood of another patient treated with extracorporeal membrane oxygenation. Susceptibility studies were performed on these three isolates and another 29 isolates that colonized or caused infection in a total of 19 patients seen over the last decade. All isolates had low minimum inhibitory concentration (MIC) values for amphotericin B (MIC90 of < or = 0.02 microgram/ml) and flucytosine (MIC90 of 0.2 microgram/ml), and a broader range of MIC values for itraconazole (MIC90 of 0.8 microgram/ml) and fluconazole (MIC90 of 4 micrograms/ml). A colorimetric method using Alamar blue reagent showed good concordance with the standard broth macrodilution method for amphotericin B, flucytosine, and fluconazole, but less good concordance for itraconazole. Serious infections with S. cerevisiae probably should be treated with amphotericin B, with or without the addition of flucytosine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9407218     DOI: 10.1016/0732-8893(95)00188-3

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.

Authors:  L Zerva; R J Hollis; M A Pfaller
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

2.  Rapid identification of Candida species with species-specific DNA probes.

Authors:  C M Elie; T J Lott; E Reiss; C J Morrison
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  Saccharomyces: A Friend or Foe in ICU (A Case Report with Solution).

Authors:  Prasoon Gupta; Y P Singh; Akhil Taneja
Journal:  Indian J Crit Care Med       Date:  2019-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.